79 results
DEF 14A
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
19 Apr 21
Definitive proxy
4:46pm
OF THE SUPERMAJORITY
VOTING STANDARDS IN OUR CHARTER AND BYLAWS
PROPOSAL 4—RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM
AUDIT … .
Susannah Gray has served on our Board and as the Chair of its Audit Committee since our IPO in November 2020. Ms. Gray served as the Chief Financial
PRE 14A
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
9 Apr 21
Preliminary proxy
4:16pm
OF THE SUPERMAJORITY
VOTING STANDARDS IN OUR CHARTER AND BYLAWS
PROPOSAL 4—RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM
AUDIT … .
Susannah Gray has served on our Board and as the Chair of its Audit Committee since our IPO in November 2020. Ms. Gray served as the Chief Financial Officer
8-K
EX-10.3
r04xsbr66fq1flq
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
10-K
EX-31.1
t74s87ag 25wlq
22 Mar 21
Annual report
4:22pm
424B4
4a6 s0obdk
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
u24r770wbu brqky37rs
25 Mar 21
Draft registration statement
12:00am
8-K
EX-2.1
onxpa c1lp
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
10-Q
EX-31.1
211tuh1fkcmnh0kb3
12 May 21
Quarterly report
4:26pm